Chargement en cours...
Exploratory in vitro evaluation of thrombin generation of eptacog beta (recombinant human fviia) and emicizumab in congenital haemophilia A plasma
INTRODUCTION/AIM: Eptacog beta is a recombinant activated human factor VII approved to treat and control bleeding in haemophilia A and B patients with inhibitors. Emicizumab is a factor VIIIa mimetic antibody approved for prophylactic treatment of haemophilia A with and without inhibitors (HAI and H...
Enregistré dans:
| Publié dans: | Haemophilia |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8048629/ https://ncbi.nlm.nih.gov/pubmed/33550714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hae.14253 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|